Science Applications International Corp
SAICScience Applications International Corporation, Inc. (SAIC) is an American technology company headquartered in Reston, Virginia that provides government services and information technology support.
Drugs in Pipeline
16
Phase 3 Programs
6
Upcoming Catalysts
3
Next Catalyst
Mar 15, 2026
TomorrowMarket Overview
Stock performance and key metrics
3 upcoming, 0 past
Progerinin Phase 2 Results Expected
Primary completion for Progerinin trial (NCT06775041) in Hutchinson-Gilford Progeria Syndrome
SourceEarnings
SAIC announced it will host a fourth quarter fiscal year 2026 earnings conference call on March 16, 2026 at 10 A.M. EDT. This is a routine investor relations announcement with no material business developments.
1 more catalyst beyond 14 days
Start a 48h free trial to see all upcoming catalysts
SST-0225 Topical Ibuprofen Cream
Acute Ankle Sprain
Eculizumab Injection
Paroxysmal Nocturnal Haemoglobinuria (PNH)
MY008211A tablets
Paroxysmal Nocturnal Hemoglobinuria
SST-0225
Delayed Onset Muscle Soreness, DOMS
SJP-0132
Dry Eye
VPM1002
Infection, Respiratory Tract
SST-6007
Sexual Arousal Disorder
IM19 CAR-T
Leukemia
Next Science Acne Gel
Acne Vulgaris
wSp vaccine
Acute Otitis Media (AOM)
BCG
Tuberculosis
IM19 CAR-T Cells
NHL
rSIFN-co Nasal Spray
COVID-19
Progerinin
Hutchinson-Gilford Progeria Syndrome
Sildenafil Cream
Erectile Dysfunction
QR052107B 100 mg
Cough
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SST-0225 Topical Ibuprofen Cream | Phase 3 | Acute Ankle Sprain | - | - |
Eculizumab Injection | Phase 3 | Paroxysmal Nocturnal Haemoglobinuria (PNH) | - | - |
MY008211A tablets | Phase 3 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
SST-0225 | Phase 3 | Delayed Onset Muscle Soreness, DOMS | - | - |
SJP-0132 | Phase 3 | Dry Eye | - | - |
VPM1002 | Phase 3 | Infection, Respiratory Tract | - | - |
SST-6007 | Phase 2 | Sexual Arousal Disorder | - | - |
IM19 CAR-T | Phase 2 | Leukemia | - | - |
Next Science Acne Gel | Phase 2 | Acne Vulgaris | - | - |
wSp vaccine | Phase 2 | Acute Otitis Media (AOM) | - | - |
BCG | Phase 2 | Tuberculosis | - | - |
IM19 CAR-T Cells | Phase 2 | NHL | - | - |
rSIFN-co Nasal Spray | Phase 2 | COVID-19 | - | - |
Progerinin | Phase 2 | Hutchinson-Gilford Progeria Syndrome | - | - |
Sildenafil Cream | Phase 2 | Erectile Dysfunction | - | - |
QR052107B 100 mg | Phase 2 | Cough | - | - |